Filing Flows

Filing Flows › Technology › Firefly Neuroscience (AIFF)

Firefly Neuroscience (AIFF) earnings and revenue breakdown

Latest: Q2 2026 · 10-Q filed Aug 11, 2026 · Firefly Neuroscience (AIFF) Q2 2026 earnings results →

Q2 2026 Revenue up 72% year over year to $514K · 386¢ of every $1 of revenue lost · operating margin -384.0%

Firefly Neuroscience made $514K in Q2 2026 (+72% Y/Y): Subscription and Circulation $243K, Service $164K, Product $92K. Operating margin -384.0%, net loss $2.0M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 11, 2026.

Revenue$514K
Year over year+72%
Operating margin-384.0%
Net earnings−$2.0M
Operating cash flow−$1.8M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $514K in Q2 2026, up 72% year over year and up 6% from the previous quarter. Subscription and Circulation was the largest line at 47% of revenue. Product added $48K year over year (up 109%), 22% of the total change. Rentals declined 84%.

Gross margin was 49.2%, down 42.4 points from Q2 2025. Operating costs exceeded revenue by $2.0M, an operating margin of -384.0%. Operating expenses grew 17% against revenue growth of 72%. The fastest-growing cost line was Research & development (+56%). The quarter ended with a net loss of $2.0M, narrower than the previous quarter's $2.0M loss.

Operating cash flow was −$1.8M. Non-cash charges added back $47K of depreciation and amortization and $268K of share-based compensation. Capital expenditures of $42K exceeded it, leaving free cash flow of −$1.8M.

Quarterly history

Firefly Neuroscience revenue by quarterFirefly Neuroscience revenue by quarter$53KQ4 2024$43KQ1 2025$299KQ2 2025$388KQ3 2025$412KQ4 2025$485KQ1 2026$514KQ2 2026
Firefly Neuroscience net earnings by quarterFirefly Neuroscience net earnings by quarter−$3.8MQ4 2024−$12.9MQ1 2025−$1.8MQ2 2025−$2.6MQ3 2025−$2.5MQ4 2025−$2.0MQ1 2026−$2.0MQ2 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q2 202610-QAug 11, 2026$514K+72%-384.0%−$2.0M−$1.8M
Q1 202610-QMay 13, 2026$485K11×-414.4%−$2.0M−$1.9M
Q4 202510-KMar 31, 2026$412K+677%-607.0%−$2.5M−$1.8M
Q3 202510-QNov 12, 2025$388K12×-684.5%−$2.6M−$1.5M
Q2 202510-QAug 13, 2025$299K30×-546.5%−$1.8M−$2.4M
Q1 202510-QMay 14, 2025$43K+258%n/m−$12.9M−$2.5M
Q4 202410-KApr 3, 2025$53K+179%n/m−$3.8M−$1.2M

Charts

Firefly Neuroscience: revenue growth, year over year and quarter over quarterFirefly Neuroscience: revenue growth, year over year and quarter over quarterY/YQ/Q+179%Q4 2024+258%-19%Q1 2025+400%+400%Q2 2025+400%+30%Q3 2025+400%+6%Q4 2025+400%+18%Q1 2026+72%+6%Q2 2026
Latest (Q2 2026): Y/Y +72%, Q/Q +6%.
Firefly Neuroscience: where the cash came from (+) and went (−), TTM to Q2 2026Firefly Neuroscience: where the cash came from (+) and went (−), TTM to Q2 2026Other financing$10.5MOperating cash flow−$7.0MCash drawn (+) / kept (−)−$3.3MOther investing−$209K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Firefly Neuroscience: profit against cash, quarter by quarterFirefly Neuroscience: profit against cash, quarter by quarterNet incomeOperating cash flow−$4.3M−$2.5MQ3 2024−$3.8M−$1.2MQ4 2024−$12.9M−$2.5MQ1 2025−$1.8M−$2.4MQ2 2025−$2.6M−$1.5MQ3 2025−$2.5M−$1.8MQ4 2025−$2.0M−$1.9MQ1 2026−$2.0M−$1.8MQ2 2026
Latest (Q2 2026): Net income −$2.0M, Operating cash flow −$1.8M.
Firefly Neuroscience in its industry: growth against margin (192 companies, SIC 7372)Firefly Neuroscience in its industry: growth against margin (192 companies, SIC 7372)revenue growth, year over year →↑ operating marginmedian +12%median 0%MSFTORCLCRMADBEXYZINTUNOWSHOPCRWVSNPSPLTRADSKElectronic Arts Inc.TEAMSSNCCDNSRBLXTWLOSNOWTTWOCRWDGENDDOGHUBSVEEVDOCUOKTANETMDBNTNXPTCTYLDBXUDTPAYCMBLYESTCPCTYZETARBRKACIWBSYGWREPATHPCORTDCOCTVFIGKVYOCOURBILLBOXCVLTDUOLSAILGTMMANHLIMEAPPFCCCYOUTTANBLKBSGTLBALRMTENBWKPRGSFRSHAPPNBANDNAVNBRZEQTWONTSKASANCXMVERXRPDSPSCBLFSLYVRNSQLYSFROGMQBBINTANCNOEVCMNABLVIAALKTAVPTSPTPDGDYNXPERAMPLDDDSKILCERTCCSICMRCMKTWHUCKCRNCPDFSWEAVSOUNINSEXZODHIIIVLiveperson IncAIMRDNMYPSUPLDKLTRBLZELAWDRTTFBBAIMAPSCCLDEXFYRDVTSSTIEGANNTWKRCATSNALFDCTSVCOMCHXAEYEZDGEADBTWFCFAISPDUOTIDNPDYNQUBTZSPCROCFATNAWRESMSIINLXBLINMSGMGEGSEGGMYSZCXAIGXAIPARAAITXBKYICYABAPCXSPAIDSNYEXYNIDAIATDSIVDAVPRBSKKYUMEWAUIDGlobal Arena Holding, Inc.ATHRVIDAQXLLIVGUPYYFNGRSVMBTransparentBusiness, Inc.SWMRAMSTTransit Pro Tech Inc.PXLWDNKCDPLSGYGYAIFF (+72%, -100%)
Services-Prepackaged Software; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Firefly Neuroscience

Firefly Neuroscience, Inc. is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. Firefly Neuroscience, Inc. is rebuilding the foundation of how electrophysiological data flows into clinical decision-making for brain health. We believe the brain is the most under-measured organ in medicine, and that the tools to change this have, until now, been inaccessible to the clinicians who need them most.

In its own words, from its 10-K, filed Mar 31, 2026.

Firefly Neuroscience against its Services-Prepackaged Software peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +72% against the peers' median +19%. Operating margin: -384.0% against the peers' median 15.2%.

CompanyQuarterRevenueY/YOp. margin
AIFF Firefly NeuroscienceQ2 2026$514K+72%-384.0%
MSFT MicrosoftQ1 FY27$92.3B+19%49.8%
ORCL OracleQ1 FY27$19.3B+30%34.8%
CRM SalesforceQ2 FY27$11.3B+11%20.5%
ADBE AdobeQ3 FY26$6.8B+13%34.8%
XYZ BlockQ3 2026$6.7B+10%6.4%
INTU IntuitQ4 FY26$4.4B+14%10.9%
NOW ServiceNowQ3 2026$4.1B+20%9.4%
SHOP ShopifyQ3 2026$3.7B+32%15.2%

Source: Firefly Neuroscience 10-Q on SEC EDGAR · CIK 803578 · Services-Prepackaged Software

13F: who owns AIFF and who is buying

Largest holders of AIFF (13F)Largest holders of AIFF (13F)Murchinson$786KVanguard Group$440KBlackRock$226KBoothbay Fund Management, LLC$216KGeode Capital Management, LLC$147KVanguard Capital Management LLC$135KJane Street Group, LLC$82KUBS Group AG$72KVanguard Fiduciary Trust$62KState Street$56K
Funds' net buying of AIFF by quarter (13F)Funds' net buying of AIFF by quarter (13F)$39K2024-09−$3K2024-12$381K2025-03$168K2025-06$823K2025-09$5K2025-12$1.4M2026-03$501K2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on AIFF

History

Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results

Compare AIFF with

中文版:Firefly Neuroscience(AIFF)财报

Español · Français